Individual generic drug information
Extracted information for Minoxidil only.
Severe hypertension, in addition to a diuretic and a beta- blocker ▶BY MOUTH ▶Adult: Initially 5 mg daily in 1–2 divided doses, then increased in steps of 5–10 mg, increased at intervals of at least 3 days; maximum 100 mg per day ▶Elderly: Initially 2.5 mg daily in 1–2 divided doses, then increased in steps of 5–10 mg, increased at intervals of at least 3 days; maximum 100 mg per day
Source page 214
Phaeochromocytoma
Source page 214
Acute porphyrias p. 1120. after myocardial infarction (until stabilised). angina
Source page 214
Extracted information for Minoxidil only.
→Appendix 1: minoxidil
Source page 214
▶Common or very common Fluid retention. hair changes. oedema. pericardial disorders. pericarditis. tachycardia ▶Rare or very rare Leucopenia. skin reactions. Stevens- Johnson syndrome. thrombocytopenia ▶Frequency not known Angina pectoris. breast tenderness. gastrointestinal disorder. pleural effusion. sodium retention. weight increased
Source page 214
Avoid—possible toxicity including reduced placental perfusion. Neonatal hirsutism reported.
Source page 214
Present in milk but not known to be harmful.
Source page 215
Use with caution in significant impairment.
Source page 215
Extracted information for Minoxidil only.
There can be variation in the licensing of different medicines containing the same drug. Tablet ▶Loniten (Pfizer Ltd) Minoxidil 2.5 mg Loniten 2.5mg tablets | 60 tablet P £8.88 DT = £8.88 Minoxidil 5 mg Loniten 5mg tablets | 60 tablet P £15.83 DT = £15.83 Minoxidil 10 mg Loniten 10mg tablets | 60 tablet P £30.68 DT = £30.68 4.1a Hypertension associated with phaeochromocytoma Other drugs used for Hypertension associated with phaeochromocytoma Propranolol hydrochloride, p. 162 VASODILATORS › PERIPHERAL VASODILATORS
Source page 215
Filter the extracted dose blocks for this individual drug.
First line only; read the complete Indications and dose section above.
Initially 5 mg daily in 1–2 divided doses, then
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 214
